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Abstract
Introduction Magnetic resonance angiography (MRA)
screening for recurrence of a coiled intracranial aneurysm
and formation of new aneurysms long-term after coiling
may induce anxiety and depression. In coiled patients, we
evaluated effects on mood and level of anxiety from long-
term follow-up MRA in comparison to general population
norms.
Methods Of 162 patients participating in a long-term
(>4.5 years) MRA follow-up after coiling, 120 completed
the EQ-5D questionnaire, a visual analog health scale and a
self-developed screening related questionnaire at the time
of MRA. Three months later, the same questionnaires were
completed by 100 of these 120 patients. Results were
compared to general population norms adjusted for gender
and age.
Results Any problem with anxiety or depression was
reported in 56 of 120 patients (47%; 95%CI38↔56%) at
baseline and 42 of 100 patients (42%; 95%CI32↔52%) at
3 months, equally for screen-positives and -negatives.
Compared to the reference population, participants scored
38% (95%CI9↔67%) and 27% (95%CI4↔50%) more
often any problem with anxiety or depression. Three
months after screening, 21% (20 of 92) of screen-
negatives and 13% (one of eight) of screen-positives
reported to be less afraid of subarachnoid hemorrhage
(SAH) compared to before screening. One of eight screen-
positives reported increased fear of SAH.
Conclusions Patients with coiled intracranial aneurysms
participating in long-term MRA screening reported signifi-
cantly more often to be anxious or depressed than a reference
group. Screening did not significantly increase anxiety or
depression temporarily. However, subjectively, patients did
report an increase in anxiety caused by screening, which
decreased after 3 months.
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Abbreviations
MRA magnetic resonance angiography
SAH subarachnoid hemorrhage
MRI magnetic resonance imaging
TOF MRA time-of-flight MRA
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Introduction
Extended imaging follow-up of coiled aneurysms that are
adequately occluded at 6 months is under debate because
the yield of clinically relevant findings appears to be low
[1–3]. Although imaging follow-up with magnetic reso-
nance angiography (MRA) has a negligible risk of
complications, a follow-up regime longer than necessary
may have a negative impact on the quality of life of these
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DOI 10.1007/s00234-010-0726-1patients. Results from screening programs in patients with
breast cancer and abdominal aortic aneurysms have
indicated that potential benefits of a positive result of
screening may be negated by reduced quality of life [4, 5].
On the other hand, a screen-negative result may increase
psychosocial wellbeing [5].
A previous study has shown that patients with a history
of subarachnoid hemorrhage (SAH) and neurosurgical
clipping have higher hospital anxiety and depression scale
scores than a reference group [6]. Anxiety seems an
important factor in assessing cost effectiveness of long-
term follow-up screening after neurosurgical aneurysm
clipping. In a cost-effectiveness study on long-term
screening after clipping of aneurysms, screening did not
increase quality adjusted life years in general, but would do
so if patients had a modest decreased quality of life from
fear for a recurrence [7].
The purpose of our study was to evaluate the impact on
anxiety and depression of long-term (more than 4.5 years)
MRA screening in patients with a coiled intracranial
aneurysm that was adequately occluded at 6 months
follow-up. We assessed anxiety and depression scores
directly after screening, before the results of the scan were
notified to the patient; and 3 months later, a possible short-
term increase in anxiety as a result of the screening would
be neutralized by 3 months [8]. We compared both scores
with scores of the general Dutch population. In addition, we
aimed to compare anxiety and depression scores of patients
with a history of SAH to patients without a history of SAH.
Methods
Selection of patients
In the Netherlands, an ongoing multi-center study called the
LOng Term follow Up Study of coiled intracranial aneurysms
(LOTUS) started in 2005. In this study, the occlusion status of
coiled intracranial aneurysms is evaluated with long-term
MRA after coiling. Review boards of the participating centers
approvedthestudyprotocol.Inclusioncriteriaforinvitationto
participate to LOTUS were: coiling of an intracranial
aneurysm more than 4.5 years earlier with adequate aneurysm
occlusion on 6 months follow-up angiography, current age
under 70 years, and no contra-indication for magnetic
resonance imaging (MRI). MRAwas performed on a 3 Tesla
scanner without contrast administration [1].
Although the main purpose of the LOTUS study is
assessment of the occlusion status of the coiled aneurysm,
also the formation of new aneurysms and growth of
additional untreated aneurysms are evaluated. Participants
are informed about the low risk of finding either an
incompletely occluded aneurysm or a newly formed or
grown aneurysm, but if found, treatment or further follow-
up must be considered in view of the risk of SAH. Within
4 weeks after the scan, participants are informed about the
scan results by telephone or at the outpatient clinic.
From November 2007 to July 2009, all participants of
the LOTUS study were invited to fill out a questionnaire
directly after the MRA. The questionnaire had to be
returned by mail within 4 weeks, before the MRA scan
results were notified to the patient. Patients who responded
in time received a second questionnaire by mail at least
3 months after the MRA. If the second questionnaire was
not returned within 2 months, patients received another
copy of the second questionnaire by mail.
Questionnaires
The questionnaire consisted of four parts. The first part was
a list of questions about patient history of SAH and family
history of SAH. Second, we used validated Dutch versions
of the EuroQol (EQ-5D) that contain five questions
addressing mobility, usual activities, pain, self-care, and
anxiety and depression, and a visual analog scale where
persons can rate their overall health state ranging from 0
(worst imaginable health state) to 100 (best imaginable
health state). Third was a self-developed list of screening
related questions (Fig. 1). In this list, patients were asked
about the frequency of thoughts about the coiled aneurysm,
about fear for a (recurrent) SAH and about sleep depriva-
tion because of worrying in relation to the aneurysm.
Answers were indicated on a Likert scale ranging from
‘always’ to ‘never’. For each question, the patient was
asked if participation in this study caused more arousal,
choosing ‘yes’ or ‘no’. Patients were asked how they felt
about the participation to the screening ranging from ‘very
content’ to ‘regret’. Finally, patients were asked if they
wanted to be screened again the next year and in 5 years.
Data analysis
The scores of the anxiety and depression question of the
EQ-5D questionnaire directly after screening and at
3 months follow-up was compared to reference data from
851 subjects in a sample survey from Rotterdam, the
Netherlands, matched for gender and age [9]. The propor-
tion of participants reporting any problem in the anxiety
and depression at baseline and at 3 months were compared
to the reference group as absolute difference in proportion
with 95% confidence interval (CI). The mean baseline EQ-
VAS scores were compared to 3 months with a paired
sample t test. Answers to the screening related questions in
the Likert scale were described and reduced to a nominal
level ‘agree’ and ‘disagree’ to compare between baseline
and follow-up measurements using χ
2 tests.
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history of a SAH were compared between baseline and at
3 months and with patients without SAH with Fisher’s
exact test. Responses to the screening-related questions
were compared between the two groups using χ
2 and
Fisher’s exact test. Data from screen-positive patients were
separately described. For the EQ-5D data-analyses, all
returned questionnaires at baseline and at 3 months were
included. For all other comparisons of data from baseline
with 3 months questionnaires, only the data of patients with
two completed questionnaires was assessed.
Results
Patient characteristics
Between September 2007 and June 2009, 312 patients were
invited to participate in the LOTUS study, and 162 patients
were enrolled to undergo an MRA scan more than 4.5 years
after coiling of an intracranial aneurysm. Reasons for patients
not to participate in the LOTUS study are summarized in Fig. 2.
Of 162 invited patients, 120 (74%) returned the
completed questionnaire in time, and 42 patients did not
want to fill out the questionnaire or were too late returning
it. The second questionnaire was sent at least 3 months after
the MRI scan to the 120 patients that completed the first
one and was returned by 100 (83%) patients mean
8.3 months (range 2.9-20.4 months) after the MRI scan.
Of 120 included patients, 82 werefemale(68%).Meanage
was 55 years (median 56, range 23-70 years). Of 120 patients,
106 (88%) had a ruptured aneurysm that was coiled and 14
(12%) were coiled for an unruptured aneurysm. Fourteen
patients (12%) had a family history of intracranial aneurysms.
EQ-5D
In the baseline questionnaire, 56 of 120 patients (47%; 95%
CI 38-56%) reported to have any problem with anxiety or
depression; and at 3 months, this was reported by 42 of 100
patients (42%, 95% CI 32-52%; Fig. 3 Table 1). If the
analysis is restricted to the subset of 100 patients who
completed the questionnaires at both assessments, the
proportions of patients with any problem with anxiety or
depression were 44% (95% CI 34-54%) at time of MRA
and 42% (95% CI 32-52%) 3 months after MRA
(difference 2%; 95%CI of difference −1 to 4%) This
indicates that anxiety or depression was not significantly
increased directly after screening compared to 3-months
Fig. 2 Flowchart showing patient selection for the LOTUS study and
the present sub-study
Fig. 1 Patients’ response to the
screening related questions at
MRI screening and after
3 months
Neuroradiology (2011) 53:343–348 345follow-up (p=0.89). However, compared to the 19% (95%
CI 16-22%) in the general Dutch population and adjusted
for gender and age, patients reported 38% (95% CI: 9-67%)
m o r eo f t e nt oh a v e‘any problem’ with anxiety or
depression in the baseline questionnaire and 27% (95% CI
4-50%) more often at 3 months (Fig. 4). Both proportions
were significantly higher (p<0.001).
EQ-VAS
Overall health in 100 patients that completed both
questionnaires was rated mean 75 points out of 100
(median 79.5, range 4-100). At 3 months, this was with
72.1 points (median 75, range 10-100), which was
significantly lower (p=0.03) (Table 1).
Screening-related questions
Answers to screening-related questions at baseline and at
3 months are shown in Fig. 1.
At time of MRA, 14 of 99 patients (14%) indicated to
think regularly or most of the time of the coiled aneurysm;
and at 3 months, this was 16 of 100 (16%). To the question
‘Did participation in this study increase frequency of these
thoughts?’, 26 of 93 (28%) of patients confirmed at
baseline and seven of 100 (7%) at 3 months; three of these
seven patients had a recurrent or new aneurysm.
Of 99 patients, 91 (92%) responded not to be afraid of a
(recurrent) SAH and 85 of 96 patients (91%) felt that
participation in the study did not increase this fear. At
3 months, 21 patients reported to be less afraid of an SAH
after the screening. Of the two patients reporting increased
fear for a SAH at 3 months, in one patient an aneurysm
recurrence was found.
Of 98 patients, 89 (91%) indicated not to sleeping
disturbances because of worries of their state of health and
participation on screening did not alter this in 91 of 100
patients (91%). At 3 months, nine patients reported to sleep
better and two to sleep worse after screening. In these two
patients, an aneurysm recurrence was found.
At 3 months, 89 of 100 participants (89%) were content
or very content with participation on the screening; no
patients regretted participation. Seventy-nine participants
(79%) were interested in a yearly screening and 89 (89%)
in screening every 5 years.
Patients with a history of SAH versus patients without SAH
Of 100 patients who completed both questionnaires, 88 had a
history of SAH and 12 had not. Forty-one of 88 SAH patients
(47%)hadanyproblemwithanxietyordepressionatbaseline;
and at 3 months, this was reported by 37 patients (42%), (p=
0.50). Three of 12 (25%) non-SAH patients had any problem
with anxiety of depression at the time of MRA, a non-
significantly lower proportion compared to SAH patients
(p=0.16). At 3 months, five of 12 (42%) non-SAH patients
reported to have any problem with anxiety or depression; this
increase was not significant (p=0.67).
Of 82 SAH patients that responded, 25 (30%) reported
an increase in frequency of thoughts about the coiled
aneurysm due to screening compared to one of 11
responding non-SAH patients (9%). This difference was
significant (p=0.04). However, at 3 months, this difference
was no longer present with six of 88 SAH patients (7%)
and one of 11 responding non-SAH patients (9%) reporting
an increase in thoughts due to screening. Screening caused
more fear for a recurrent SAH at baseline in SAH patients
(nine of 84 respondents, 11%) compared to no non-SAH
patients (0%); but at 3 months, this difference was no
longer present. To the question about disturbed sleep
because of worries about health, SAH patients and non-
SAH patients responded comparable.
Screen-positive patients
In eight of 100 patients who completed both questionnaires,
a new finding was present on MRI. All eight patients had a
history of SAH and two had familial intracranial
Fig. 4 Patients reporting to have ‘any problem’ with anxiety or
depression in the EQ-5D questionnaire at MRI screening and after
3 months compared to Dutch general population norms
Fig. 3 Patients’ response to “Are you anxious or depressed?”
question at MRI screening and after 3 months
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recurrence or de novo aneurysm, three patients had small
aneurysm recurrences for which extended follow-up was
recommended, and one patient had a small recurrence that
needed no further follow-up. At 3 months, three of eight
(38%) screen-positive patients reported ‘any problem’ with
anxiety, compared to 39 of 92 (42%) screen negatives. Two
screen-positive patients scored more anxiety or depression
at 3 months than at baseline. All eight screen positives were
very content with the participation in the study.
Discussion
In this study, we found that patients with a coiled intracranial
aneurysm that were screened with MRI more than 4.5 years
after coiling are more anxious or depressed at the time of
screening and 3 months thereafter compared to Dutch
general population norms. Half of the patients reported to
have a problem with anxiety or depression at the time of
screening. Screening did not significantly increase anxiety or
depression temporarily. However, a quarter of the patients
indicated that screening caused more frequent thinking about
the coiled aneurysm and one in ten reported to be more
afraid for recurrent SAH, even before results of screening
were communicated. Three months after screening, one in
seven patients reported that screening had decreased
thoughts of their coiled aneurysm and one in five was less
afraid of a recurrent SAH.
The EQ-5D questionnaire we used is a rough tool and
cannot assess a moderate temporary increase in anxiety or
depression caused by screening in our population. However,
our study does rule out a major impactof long-term follow-up
screening on quality of life and in particular on anxiety or
depression. Our screening-related questions are not validated,
but may imply subjective feelings of temporary increased fear
in participants. A negative screening result, although positive
news for the patient, did not substantially decrease anxiety or
depression,butprovidedasubjectivefeelingofrelieveinmost
participants and no patients regretted participation. Surpris-
ingly, a screen-positive result did not influence quality of life,
nor did it cause a subjective feeling of increased fear for SAH
in most patients. Compared to patients without a history of
SAH, patients with a history of SAH are more anxious at the
time of long-term follow-up screening.
In a comparable long-term follow-up screening study of
patients with a ruptured aneurysm that was surgically
clipped, patients were also more anxious or depressed than
a general population group [6].
Our study has several limitations. First, we only invited
participants of our multi-center long-term follow-up study
after coiling (LOTUS) to fill out the questionnaires. Partici-
pation in LOTUS indicated an a priori interest in screening.
We did not invite the patients who declined screening, either
out of lack of interest or out of fear for the screening or its
results.Iffear ofscreening would be a major reason to decline
screening, our study is likely to underestimate the true anxiety
scoresinpatientslong-termaftercoiling.However,thegoalof
this study was to assess impact on mood and anxiety of
patients that participate in a long-term follow-up screening;
hence, non-participants are not exposed to this additional
burden. Second, although the same questionnaires were filled
out at the time of MRI and 3 months later in order to pick up a
possible temporary increase in anxiety induced by the
screening, our study lacks a true baseline measurement and
we have no solid proof that temporarily increased anxiety will
have resided within 3 months. If this duration is longer, we
have measured too short [8]. Third, although this is the
largest study to assess anxiety in this specific patient group
to date, our sample size was too small to compare different
subgroups, for example patients with and without familial
intracranial aneurysms and screen-positives and screen-
negatives. In our comparison of patients with or without a
history of SAH, we encountered large confidence intervals
because of the small sample of patients without a history of
SAH.
Table 1 Patient characteristics, EQ-5D anxiety/depression scores and VAS scores of participants compared to Dutch general population norms.
Baseline
(n=120)
Follow-up
(n=100)
Reference group
a
(n=851)
Screen-positives at follow-up
(n=8)
Number of men 38 (32%) 33 (33%) 384 (45%) 1 (13%)
Mean age (median, range) 55 (56, 23-70) 55 (57, 23-70) –
d 56 (57, 46-63)
Number with anxiety or depression
b 56 (47%) 42 (42%) 161 (19%) 3 (38%)
Mean VAS
c 75.0 72.1 80.3 59.0
aReference group from Essink-Bot et al. [9] published in Health Economics in 1993
bNumber of participants reporting to have ‘any problem’ with anxiety or depression in the Dutch EQ-5D questionnaire
cVAS from the EQ-5D questionnaire with scores from 0 to 100, with a score of 0 being the worst and 100 the best imaginable health state
dPatient age is reported per decade; 13%=18-29 years, 19%=30-39 years, 13%=40-49 years, 12%=50-59 years, 16%=60-69 years, 17%=70-79 years,
10%=80+ years
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effectiveness of long-term follow-up screening after
neurosurgical aneurysm clipping [7]. To our knowledge,
our study is the first to assess psychosocial impact of long-
term MRA screening in patients with a history of
intracranial aneurysm coiling. Screening did not tempo-
rarily increase anxiety, nor did a negative screening result
give a substantial decrease in anxiety. Aneurysms that are
coiled with adequate occlusion at 6 months follow-up are
likely to remain sufficiently occluded at long-term follow-
up [1]. In addition, the frequency of new aneurysm
formation and enlargement of untreated aneurysms in this
patient population appears to be low [3]. Clinical
relevance of long-term screening of patients with ade-
quately occluded coiled aneurysms is doubtful [10],
emphasized by our study results that patients with a coiled
intracranial aneurysm are more anxious compared to a
reference group.
Conclusion
Patients with a history of aneurysm coiling and especially
patients with a history of SAH and coiling are more anxious
or depressed compared to a Dutch general population
group. Long-term follow-up screening does not induce a
major increase in anxiety or depression temporarily, and a
negative screening outcome does not give a substantial
decrease in the patients’ feelings of anxiety or depression.
The decision to subject patients with a coiled intracranial
aneurysm to long-term follow-up should be made
considering clinical relevance only, and follow-up is not
recommended for the sole purpose of reassuring the patient.
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